Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators report.

Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators report.